Xie He-Hui, Chen Yuan-Yuan, Miao Chao-Yu, Shen Fu-Ming, Su Ding-Feng
Department of Pharmacology, Second Military Medical University, Shanghai, China.
Cardiovasc Drugs Ther. 2005 Dec;19(6):391-7. doi: 10.1007/s10557-005-5734-8.
This study was designed to investigate the effects of candesartan on blood pressure (BP) and blood pressure variability (BPV) reductions, baroreflex sensitivity (BRS) amelioration, and organ protection in spontaneously hypertensive rats (SHR).
Studies were performed in two groups of SHR (n = 13 for control rats; and n = 20 for candesartan-treated rats) and one group of WKY rats (n = 13). Candesartan (3 mg /kg/d) was given in rat chow for 4 months. BP was then continuously recorded for 24 hours in conscious state. After the determination of BRS, rats were killed for organ-damage evaluation.
Long-term treatment with candesartan significantly reduced BP and BPV expressed by both standard deviation and variation coefficient of BP, enhanced BRS and produced obvious organ protection. Compared with BP level, BPV and BRS values showed a closer or similar relationship with organ-damage parameters in SHR. Multiple regression analysis showed that the decrease in left ventricular hypertrophy was most closely associated with the increase in BRS, whereas the decrease in aortic hypertrophy was most closely associated with the decrease in 24-hour systolic BPV, and the amelioration in renal lesions, with the increase in BRS and the decrease in 24-hour systolic BPV.
long-term treatment with candesartan results in organ protection in SHR. Besides BP reduction, the decrease in BPV and the restoration of BRS are significantly related to this organ protection.
本研究旨在探讨坎地沙坦对自发性高血压大鼠(SHR)血压(BP)降低、血压变异性(BPV)降低、压力反射敏感性(BRS)改善及器官保护的作用。
对两组SHR(对照组大鼠n = 13;坎地沙坦治疗组大鼠n = 20)和一组WKY大鼠(n = 13)进行研究。将坎地沙坦(3毫克/千克/天)添加到大鼠饲料中,持续给药4个月。然后在清醒状态下连续记录24小时血压。测定BRS后,处死大鼠进行器官损伤评估。
坎地沙坦长期治疗可显著降低BP及以BP标准差和变异系数表示的BPV,增强BRS,并产生明显的器官保护作用。与BP水平相比,BPV和BRS值与SHR器官损伤参数的关系更为密切或相似。多元回归分析表明,左心室肥厚的减轻与BRS的增加最为密切相关,而主动脉肥厚的减轻与24小时收缩压BPV的降低最为密切相关,肾损伤的改善与BRS的增加和24小时收缩压BPV的降低有关。
坎地沙坦长期治疗可使SHR获得器官保护。除降低BP外,BPV的降低和BRS的恢复与这种器官保护显著相关。